伊伐布雷定与噩梦：一种此前未报告的不良反应。 - Suppr

Suppr

超能文献

Ivabradine and nightmares: a previously unreported adverse reaction.

作者信息

Lappegård Knut Tore, Nordmo Elisabet

出版信息

Eur J Clin Pharmacol. 2011 Dec;67(12):1313-4. doi: 10.1007/s00228-011-1085-5. Epub 2011 Jun 24.

DOI:10.1007/s00228-011-1085-5

PMID:21701883

Abstract

摘要

相似文献

Ivabradine and nightmares: a previously unreported adverse reaction.伊伐布雷定与噩梦：一种此前未报告的不良反应。

Eur J Clin Pharmacol. 2011 Dec;67(12):1313-4. doi: 10.1007/s00228-011-1085-5. Epub 2011 Jun 24.

Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope.伊伐布雷定治疗窦速介导的血管迷走性晕厥。

Europace. 2014 Feb;16(2):284-8. doi: 10.1093/europace/eut226. Epub 2013 Sep 26.

Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.心脏移植后患者心脏变时功能的控制：伊伐布雷定和琥珀酸美托洛尔对去神经心脏静息心率的影响。

Clin Res Cardiol. 2018 Feb;107(2):138-147. doi: 10.1007/s00392-017-1165-3. Epub 2017 Nov 2.

I channel blocker ivabradine vs. β-blockers for sinus tachycardia in patients with takotsubo syndrome.伊伐布雷定（一种I通道阻滞剂）与β受体阻滞剂治疗应激性心肌病患者窦性心动过速的对比研究

Int J Cardiol. 2016 Nov 15;223:877-878. doi: 10.1016/j.ijcard.2016.08.281. Epub 2016 Aug 18.

Treatment of inappropriate sinus tachycardia with ivabradine.静脉注射伊伐布雷定治疗不适当窦性心动过速。

Wien Klin Wochenschr. 2009;121(21-22):715-8. doi: 10.1007/s00508-009-1265-9.

Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.伊伐布雷定对永久性窦性心动过速心脏移植受者移植心脏功能及运动能力的影响。

Clin Res Cardiol. 2008 Nov;97(11):811-9. doi: 10.1007/s00392-008-0690-5. Epub 2008 Jul 21.

Ivabradine in patients with inappropriate sinus tachycardia.伊伐布雷定治疗不适当窦性心动过速患者。

Naunyn Schmiedebergs Arch Pharmacol. 2010 Dec;382(5-6):483-6. doi: 10.1007/s00210-010-0565-y. Epub 2010 Sep 22.

Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.伊伐布雷定可有效且耐受良好地持久减少心脏移植术后心动过速：48 个月研究结果。

Clin Res Cardiol. 2012 Aug;101(8):631-6. doi: 10.1007/s00392-012-0436-2. Epub 2012 Mar 4.

Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation.伊伐布雷定在异基因造血细胞移植后急性心力衰竭合并窦性心动过速患者中的应用

Intern Med. 2023 Mar 1;62(5):813. doi: 10.2169/internalmedicine.9818-22. Epub 2022 Jul 22.

The use of ivabradine for inappropriate sinus tachycardia.伊伐布雷定用于不适当窦性心动过速的治疗。

Acta Cardiol. 2011 Apr;66(2):259-62. doi: 10.1080/ac.66.2.2071262.

引用本文的文献

Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox database.依伐布雷定在孕妇中的应用-治疗指征和妊娠结局：德国胚胎毒性数据库评估。

Eur J Clin Pharmacol. 2021 Jul;77(7):1029-1037. doi: 10.1007/s00228-020-03066-w. Epub 2021 Jan 26.

本文引用的文献

Single centre experience of ivabradine in postural orthostatic tachycardia syndrome.体位性心动过速综合征中伊伐布雷定的单中心经验。

Europace. 2011 Mar;13(3):427-30. doi: 10.1093/europace/euq390. Epub 2010 Nov 9.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.依伐布雷定治疗慢性心力衰竭的疗效评价（SHIFT）：一项随机、安慰剂对照研究

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1.

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.心率作为慢性心力衰竭的危险因素（SHIFT）：一项随机安慰剂对照试验中心率与结局的关系。

Lancet. 2010 Sep 11;376(9744):886-94. doi: 10.1016/S0140-6736(10)61259-7.

Inappropriate sinus tachycardia - successful treatment with ivabradine.不适当窦性心动过速——伊伐布雷定静脉注射治疗成功。

Kardiol Pol. 2010 Aug;68(8):935-7.

Ivabradine: the evidence of its therapeutic impact in angina.伊伐布雷定：其对心绞痛治疗作用的证据

Core Evid. 2008 Jun;3(1):1-12. doi: 10.3355/ce.2008.008.

Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.伊伐布雷定治疗四例不适当窦性心动过速患者的疗效：基于心电图、动态心电图监测、运动耐量和生活质量评估的三个月经验。

Cardiol J. 2010;17(2):166-71.

Ivabradine to treat inappropriate sinus tachycardia after the fast pathway ablation in a patient with severe pectus excavatum.伊伐布雷定治疗一名严重漏斗胸患者经快速径路消融术后的不适当窦性心动过速。

Pacing Clin Electrophysiol. 2010 Mar;33(3):e32-5. doi: 10.1111/j.1540-8159.2009.02587.x. Epub 2009 Oct 10.

A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine.1例因不适当窦性心动过速所致心肌病经伊伐布雷定治愈

Pacing Clin Electrophysiol. 2009 Jul;32(7):942-4. doi: 10.1111/j.1540-8159.2009.02414.x.

Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and a dual chamber pacemaker.伊伐布雷定治疗体位性直立性心动过速综合征合并双腔起搏器患者的不适当窦性心动过速

Pacing Clin Electrophysiol. 2009 Jan;32(1):131-3. doi: 10.1111/j.1540-8159.2009.02186.x.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.伊伐布雷定用于稳定型冠状动脉疾病和左心室收缩功能障碍患者（BEAUTIFUL）：一项随机、双盲、安慰剂对照试验。

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验